 Monopar Therapeutics Inc. today announced that it has priced an initial public offering of 1,111,112 shares of its common stock at 8.00 per share. The shares are expected to begin trading on the Nasdaq Capital Market on December 19, 2019 under the symbol MNPR. The offering is expected to close on December 23, 2019, subject to the satisfaction of customary closing conditions. JonesTrading Institutional Services LLC acted as Lead Bookrunning Manager and Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as Co-Manager for the offering. 